Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Jim Van Os:

Schizophrenia. Kahn RS et al. Nat Rev Dis Primers. (2015)

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Marshall CR et al. Nat Genet. (2017)

Schizophrenia. van Os J et al. Lancet. (2009)

Search results

Items: 1 to 20 of 633

1.

Decreasing Stigmatization: Reducing the Discrepancy Between "Us" and "Them". An Intervention for Mental Health Care Professionals.

Helmus K, Schaars IK, Wierenga H, de Glint E, van Os J.

Front Psychiatry. 2019 May 31;10:243. doi: 10.3389/fpsyt.2019.00243. eCollection 2019.

2.

Evidence for interaction between genetic liability and childhood trauma in the development of psychotic symptoms.

Pinckaers FME, Rotee ILM, Nwosu CV, Krolinski P, Smeets APW, Gülöksüz S, de Jong L, Vaessen TSJ, Damen T, Uittenboogaard A, Schäfer AT, Menne-Lothmann C, Decoster J, van Winkel R, Collip D, Delespaul P, De Hert M, Derom C, Thiery E, Jacobs N, Wichers M, Rutten BPF, van Os J, Drukker M.

Soc Psychiatry Psychiatr Epidemiol. 2019 Jun 17. doi: 10.1007/s00127-019-01711-z. [Epub ahead of print]

PMID:
31209522
3.

The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia.

Richards AL, Pardiñas AF, Frizzati A, Tansey KE, Lynham AJ, Holmans P, Legge SE, Savage JE, Agartz I, Andreassen OA, Blokland GAM, Corvin A, Cosgrove D, Degenhardt F, Djurovic S, Espeseth T, Ferraro L, Gayer-Anderson C, Giegling I, van Haren NE, Hartmann AM, Hubert JJ, Jönsson EG, Konte B, Lennertz L, Olde Loohuis LM, Melle I, Morgan C, Morris DW, Murray RM, Nyman H, Ophoff RA; GROUP Investigators, van Os J; EUGEI WP2 Group; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Petryshen TL, Quattrone D, Rietschel M, Rujescu D, Rutten BPF, Streit F, Strohmaier J, Sullivan PF, Sundet K, Wagner M, Escott-Price V, Owen MJ, Donohoe G, O'Donovan MC, Walters JTR.

Schizophr Bull. 2019 Jun 17. pii: sbz061. doi: 10.1093/schbul/sbz061. [Epub ahead of print]

PMID:
31206164
4.

White matter microstructure and network-connectivity in emerging adults with subclinical psychotic experiences.

Michielse S, Lange I, Bakker J, Goossens L, Verhagen S, Wichers M, Lieverse R, Schruers K, van Amelsvoort T, van Os J, Marcelis M.

Brain Imaging Behav. 2019 Jun 10. doi: 10.1007/s11682-019-00129-0. [Epub ahead of print]

PMID:
31183775
5.

Clinical guidelines on antidepressant withdrawal urgently need updating.

Davies J, Read J, Hengartner MP, Cosci F, Fava G, Chouinard G, van Os J, Nardi A, Gøtzsche P, Groot P, Offidani E, Timimi S, Moncrieff J, Spada M, Guy A.

BMJ. 2019 May 20;365:l2238. doi: 10.1136/bmj.l2238. No abstract available.

PMID:
31109968
6.

Identifying psychosis spectrum disorder from experience sampling data using machine learning approaches.

Stamate D, Katrinecz A, Stahl D, Verhagen SJW, Delespaul PAEG, van Os J, Guloksuz S.

Schizophr Res. 2019 May 16. pii: S0920-9964(19)30161-6. doi: 10.1016/j.schres.2019.04.028. [Epub ahead of print]

PMID:
31104913
7.

Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk.

Huckins LM, Dobbyn A, Ruderfer DM, Hoffman G, Wang W, Pardiñas AF, Rajagopal VM, Als TD, T Nguyen H, Girdhar K, Boocock J, Roussos P, Fromer M, Kramer R, Domenici E, Gamazon ER, Purcell S; CommonMind Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium; iPSYCH-GEMS Schizophrenia Working Group, Demontis D, Børglum AD, Walters JTR, O'Donovan MC, Sullivan P, Owen MJ, Devlin B, Sieberts SK, Cox NJ, Im HK, Sklar P, Stahl EA.

Nat Genet. 2019 Jun;51(6):1068. doi: 10.1038/s41588-019-0435-6.

8.

Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study.

Menghini-Müller S, Studerus E, Ittig S, Heitz U, Egloff L, Andreou C, Valmaggia LR, Kempton MJ, van der Gaag M, de Haan L, Nelson B, Barrantes-Vidal N, Nordentoft M, Ruhrmann S, Sachs G, Rutten BP, Os JV, Riecher-Rössler A; EU-GEI High Risk Study Group, McGuire P, Valmaggia LR, Kempton MJ, Calem M, Tognin S, Modinos G, de Haan L, van der Gaag M, Velthorst E, Kraan TC, van Dam DS, Burger N, Nelson B, McGorry P, Amminger GP, Pantelis C, Politis A, Goodall J, Riecher-Rössler A, Borgwardt S, Rapp C, Ittig S, Studerus E, Smieskova R, Bressan R, Gadelha A, Brietzke E, Asevedo G, Asevedo E, Zugman A, Barrantes-Vidal N, Domínguez-Martínez T, Racioppi A, Cristóbal-Narváez P, Kwapil TR, Monsonet M, Kazes M, Daban C, Bourgin J, Gay O, Mam-Lam-Fook C, Krebs MO, Nordholm D, Randers L, Krakauer K, Glenthøj L, Glenthøj B, Nordentoft M, Ruhrmann S, Gebhard D, Arnhold J, Klosterkötter J, Sachs G, Lasser I, Winklbaur B, Delespaul PA, Rutten BP, van Os J.

Eur Psychiatry. 2019 Jun;59:52-59. doi: 10.1016/j.eurpsy.2019.04.007. Epub 2019 May 7.

PMID:
31075522
9.

The impact of adverse childhood experiences on EMG reactivity: A proof of concept study.

Marsman A, Luijcks R, Vossen C, van Os J, Lousberg R.

PLoS One. 2019 May 9;14(5):e0216657. doi: 10.1371/journal.pone.0216657. eCollection 2019.

10.

Mindfulness-Based Intervention for People With Dementia and Their Partners: Results of a Mixed-Methods Study.

Berk L, Warmenhoven F, Stiekema APM, van Oorsouw K, van Os J, de Vugt M, van Boxtel M.

Front Aging Neurosci. 2019 Apr 24;11:92. doi: 10.3389/fnagi.2019.00092. eCollection 2019.

11.

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran E, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşog Lu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O'Donovan M, Rutten BPF, van Os J.

World Psychiatry. 2019 Jun;18(2):173-182. doi: 10.1002/wps.20629.

12.

Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling.

van Rooijen G, van Rooijen M, Maat A, Vermeulen JM, Meijer CJ, Ruhé HG, de Haan L; GROUP investigators; Genetic Risk and Outcome of Psychosis investigators:, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Amelsvoort T, van Haren NE, van Os J, van Winkel R.

Schizophr Res. 2019 Jun;208:82-89. doi: 10.1016/j.schres.2019.04.011. Epub 2019 Apr 29.

PMID:
31047723
13.

Cortical patterning of abnormal morphometric similarity in psychosis is associated with brain expression of schizophrenia-related genes.

Morgan SE, Seidlitz J, Whitaker KJ, Romero-Garcia R, Clifton NE, Scarpazza C, van Amelsvoort T, Marcelis M, van Os J, Donohoe G, Mothersill D, Corvin A, Pocklington A, Raznahan A, McGuire P, Vértes PE, Bullmore ET.

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9604-9609. doi: 10.1073/pnas.1820754116. Epub 2019 Apr 19.

14.

Gene expression imputation across multiple brain regions provides insights into schizophrenia risk.

Huckins LM, Dobbyn A, Ruderfer DM, Hoffman G, Wang W, Pardiñas AF, Rajagopal VM, Als TD, T Nguyen H, Girdhar K, Boocock J, Roussos P, Fromer M, Kramer R, Domenici E, Gamazon ER, Purcell S; CommonMind Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium; iPSYCH-GEMS Schizophrenia Working Group, Demontis D, Børglum AD, Walters JTR, O'Donovan MC, Sullivan P, Owen MJ, Devlin B, Sieberts SK, Cox NJ, Im HK, Sklar P, Stahl EA.

Nat Genet. 2019 Apr;51(4):659-674. doi: 10.1038/s41588-019-0364-4. Epub 2019 Mar 25. Erratum in: Nat Genet. 2019 Jun;51(6):1068.

PMID:
30911161
15.

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM; EU-GEI WP2 Group.

Lancet Psychiatry. 2019 May;6(5):427-436. doi: 10.1016/S2215-0366(19)30048-3. Epub 2019 Mar 19.

16.

Toward incorporating genetic risk scores into symptom networks of psychosis.

Isvoranu AM, Guloksuz S, Epskamp S, van Os J, Borsboom D; GROUP Investigators.

Psychol Med. 2019 Mar 14:1-8. doi: 10.1017/S003329171900045X. [Epub ahead of print]

PMID:
30867074
17.

Childhood theory of mind does not predict psychotic experiences and social functioning in a general population sample of adolescents.

Steenhuis LA, Pijnenborg GHM, van Os J, Aleman A, Nauta MH, Bartels-Velthuis AA.

PLoS One. 2019 Feb 28;14(2):e0213165. doi: 10.1371/journal.pone.0213165. eCollection 2019.

18.

Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia.

Harold D, Connolly S, Riley BP, Kendler KS, McCarthy SE, McCombie WR, Richards A, Owen MJ, O'Donovan MC, Walters J; Wellcome Trust Case Control Consortium 2; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Donohoe G, Gill M, Corvin A, Morris DW.

Am J Med Genet B Neuropsychiatr Genet. 2019 Apr;180(3):223-231. doi: 10.1002/ajmg.b.32716. Epub 2019 Feb 23.

PMID:
30801977
19.

Psychometric liability to psychosis and childhood adversities are associated with shorter telomere length: A study on schizophrenia patients, unaffected siblings, and non-clinical controls.

Çevik B, Mançe-Çalışır Ö, Atbaşoğlu EC, Saka MC, Alptekin K, Üçok A, Sırmatel B, Gülöksüz S, Tükün A, van Os J, Gümüş-Akay G.

J Psychiatr Res. 2019 Apr;111:169-185. doi: 10.1016/j.jpsychires.2019.01.022. Epub 2019 Feb 8.

PMID:
30776705
20.

The predictive value of neural reward processing on exposure therapy outcome: Results from a randomized controlled trial.

Papalini S, Lange I, Bakker J, Michielse S, Marcelis M, Wichers M, Vervliet B, van Os J, Van Amelsvoort T, Goossens L, Schruers K.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:339-346. doi: 10.1016/j.pnpbp.2019.02.002. Epub 2019 Feb 11. Review.

PMID:
30763673

Supplemental Content

Loading ...
Support Center